Enzastaurin and hepatic function abnormal Patient Reports February 09, 2012

Enzastaurin Side Effects Report #5564506-4
Enzastaurin side effect was reported by a Physician from JAPAN on Dec 03, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Enzastaurin. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Enzastaurin dosage: 1125 MG, UNK. During the same period patient was treated with PEMETREXED, AMLODIN, LIPITOR, CLARITIN, MYSER, KERATINAMIN. Patient was hospitalized. Patient recovered.